Michelle A. Peluso - 01 Apr 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role: EVP and Co-President of Retail
Signature: /s/ Michelle A. Peluso
Issuer symbol: CVS
Transactions as of: 01 Apr 2023
Net transactions value: -$685,584
Form type: 4
Filing time: 04 Apr 2023, 16:35:23 UTC
Previous filing: 01 Mar 2023
Next filing: 14 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CVS	Common Stock	Tax liability	$7,304,599	-98,299	-44%	$74.31	124,383	01 Apr 2023	Direct	F1
holding	CVS	Common Stock (Restricted)						55,042	01 Apr 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVS	Stock Option	Award	$6,619,015	+89,073		$74.31	89,073	01 Apr 2023	Common Stock	89,073	$74.31	Direct	F4
holding	CVS	Stock Option						86,386	01 Apr 2023	Common Stock	86,386	$74.30	Direct	F2
holding	CVS	Stock Option						57,172	01 Apr 2023	Common Stock	57,172	$101.09	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a performance stock unit award.
F2	Option became exercisable in four equal annual installments, commencing 4/1/2022.
F3	Option became exercisable in four equal annual installments, commencing 4/1/2023.
F4	Option becomes exercisable in four equal annual installments, commencing 4/1/2024.